Literature DB >> 33058753

Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.

Sina Schwarzkopf, Adalbert Krawczyk, Dietmar Knop, Hannes Klump, Andreas Heinold, Falko M Heinemann, Laura Thümmler, Christian Temme, Marianne Breyer, Oliver Witzke, Ulf Dittmer, Veronika Lenz, Peter A Horn, Monika Lindemann.   

Abstract

We investigated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who had PCR-confirmed SARS-CoV-2 infection. Sixty days after onset of symptoms, 13/78 (17%) study participants had borderline or negative results to an ELISA detecting IgG against the S1 protein of SARS-CoV-2. We analyzed participants with PCR-confirmed infection who had strong antibody responses (ratio >3) as positive controls and participants without symptoms of SARS-CoV-2 infection and without household contact with infected patients as negative controls. Using interferon-γ ELISpot, we observed that 78% of PCR-positive volunteers with undetectable antibodies showed T cell immunity against SARS-CoV-2. We observed a similar frequency (80%) of T-cell immunity in convalescent donors with strong antibody responses but did not detect immunity in negative controls. We concluded that, in convalescent patients with undetectable SARS-CoV-2 IgG, immunity may be mediated through T cells.

Entities:  

Keywords:  B cells; COVID-19; ELISpot; PCR-confirmed infection; SARS; SARS-CoV-2; T cells; cellular immunity; convalescent plasma; coronavirus disease; respiratory infections; seronegativity; severe acute respiratory syndrome; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Year:  2020        PMID: 33058753     DOI: 10.3201/2701.203772

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  43 in total

1.  Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy.

Authors:  David J Chung; Gunjan L Shah; Roni Tamari; Ioannis Politikos; David A Knorr; Santosha A Vardhana; Jennifer C Young; LeeAnn T Marcello; Sital Doddi; Sean M Devlin; Lakshmi V Ramanathan; Melissa S Pessin; Erica Dunn; Meighan Palazzo; Christina D Bravo; Genovefa A Papanicolaou; Mini Kamboj; Miguel Angel Perales
Journal:  Blood Cancer Discov       Date:  2021-09-13

2.  The Possible Role of Sex As an Important Factor in Development and Administration of Lipid Nanomedicine-Based COVID-19 Vaccine.

Authors:  Elisabetta Vulpis; Francesca Giulimondi; Luca Digiacomo; Alessandra Zingoni; Reihaneh Safavi-Sohi; Shahriar Sharifi; Giulio Caracciolo; Morteza Mahmoudi
Journal:  Mol Pharm       Date:  2021-05-13       Impact factor: 4.939

3.  Determinants of IgG antibodies kinetics after severe and critical COVID-19.

Authors:  Julien De Greef; Anaïs Scohy; Francis Zech; Frank Aboubakar; Charles Pilette; Ludovic Gerard; Lucie Pothen; Halil Yildiz; Leïla Belkhir; Jean Cyr Yombi
Journal:  J Med Virol       Date:  2021-05-12       Impact factor: 20.693

4.  Analytical Validation and Clinical Application of Rapid Serological Tests for SARS-CoV-2 Suitable for Large-Scale Screening.

Authors:  Amedeo De Nicolò; Valeria Avataneo; Jessica Cusato; Alice Palermiti; Jacopo Mula; Elisa De Vivo; Miriam Antonucci; Stefano Bonora; Andrea Calcagno; Giovanni Di Perri; Francesco Giuseppe De Rosa; Antonio D'Avolio
Journal:  Diagnostics (Basel)       Date:  2021-05-12

5.  Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection.

Authors:  Marc Scherlinger; Renaud Felten; Floriane Gallais; Charlotte Nazon; Emmanuel Chatelus; Luc Pijnenburg; Amaury Mengin; Adrien Gras; Pierre Vidailhet; Rachel Arnould-Michel; Sabrina Bibi-Triki; Raphaël Carapito; Sophie Trouillet-Assant; Magali Perret; Alexandre Belot; Seiamak Bahram; Laurent Arnaud; Jacques-Eric Gottenberg; Samira Fafi-Kremer; Jean Sibilia
Journal:  Infect Dis Ther       Date:  2021-07-10

6.  Field and Molecular Epidemiology: How Viral Sequencing Changed Transmission Inferences in the First Portuguese SARS-CoV-2 Infection Cluster.

Authors:  Nicole Pedro; Veronica Fernandes; Bruno Cavadas; João Tiago Guimarães; Henrique Barros; Margarida Tavares; Luisa Pereira
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

7.  Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine.

Authors:  Chiara Agrati; Concetta Castilletti; Delia Goletti; Silvia Meschi; Alessandra Sacchi; Giulia Matusali; Veronica Bordoni; Linda Petrone; Daniele Lapa; Stefania Notari; Valentina Vanini; Francesca Colavita; Alessandra Aiello; Alessandro Agresta; Chiara Farroni; Germana Grassi; Sara Leone; Francesco Vaia; Maria Rosaria Capobianchi; Giuseppe Ippolito; Vincenzo Puro
Journal:  Microorganisms       Date:  2021-06-16

8.  The Beauty of Simplicity: Delayed-Type Hypersensitivity Reaction to Measure Cellular Immune Responses in RNA-SARS-Cov-2 Vaccinated Individuals.

Authors:  Yvelise Barrios; Andres Franco; Inmaculada Sánchez-Machín; Paloma Poza-Guedes; Ruperto González-Pérez; Victor Matheu
Journal:  Vaccines (Basel)       Date:  2021-06-01

9.  A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.

Authors:  Eszter Somogyi; Zsolt Csiszovszki; Levente Molnár; Orsolya Lőrincz; József Tóth; Sofie Pattijn; Jana Schockaert; Aurélie Mazy; István Miklós; Katalin Pántya; Péter Páles; Enikő R Tőke
Journal:  Front Genet       Date:  2021-06-23       Impact factor: 4.599

10.  Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.

Authors:  Sophie Steiner; Tatjana Schwarz; Victor M Corman; Franziska Sotzny; Sandra Bauer; Christian Drosten; Hans-Dieter Volk; Carmen Scheibenbogen; Leif G Hanitsch
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.